Some parameters of the immune system at schizophrenia therapy with chlorpromazine and zetidoline.
Tůma
I
I
Dept. of Psychiatry, Hradec Králové.
Zapletálek
M
M
Krejsek
J
J
Pidrman
V
V
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007107:Immune System / Q000187:drug effects / Q000503:physiopathology*; D007136:Immunoglobulins / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy / Q000276:immunology*
D014150:Antipsychotic Agents; D007093:Imidazoles; D007136:Immunoglobulins; C027277:zetidoline; D002746:Chlorpromazine